NASDAQ:CORT – Knox Daily

Stock Earnings

Taking a Closer Look At Corcept Therapeutics Inc (CORT) Following Its Recent Trade

Corcept Therapeutics Inc’s filing revealed that its Officer Guyer William acquired Company’s shares for reported $0.49 million on Nov 01

Insiders Updates

Corcept Therapeutics Inc [CORT] Chief Development Officer makes an insider purchase of 10,000 shares worth 0.46 million.

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Analysts Viewpoint

Corcept Therapeutics Inc [CORT] Guyer William sells 10,000 Shares for $0.46 million

Corcept Therapeutics Inc’s recent filing unveils that its Chief Development Officer Guyer William unloaded Company’s shares for reported $0.46 million

Analysts Viewpoint

CORT Stock Sees Surge of Approximately 0.15% in Last Five Days

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Corcept Therapeutics Inc [CORT] Insider Guyer William sells 10,000 Shares for $10,000

Corcept Therapeutics Inc’s filing revealed that its Chief Development Officer Guyer William unloaded Company’s shares for reported $0.46 million on

Insiders Updates

Corcept Therapeutics Inc [NASDAQ: CORT] Sees Decrease in Stock Value

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Analysts Viewpoint

Truist upgrades Corcept Therapeutics Inc (CORT) rating to a Buy

Corcept Therapeutics Inc’s filing revealed that its Chief Development Officer Guyer William unloaded Company’s shares for reported $0.46 million on

Analysts Viewpoint

Corcept Therapeutics Inc [NASDAQ: CORT] Sees Decrease in Stock Value

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Recent Insider Activity Suggests Potential Gains for Corcept Therapeutics Inc (CORT)

Corcept Therapeutics Inc’s recent filing unveils that its Chief Development Officer Guyer William unloaded Company’s shares for reported $0.46 million

Analysts Viewpoint

Corcept Therapeutics Inc [NASDAQ: CORT] Sees Decrease in Stock Value

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Tag: NASDAQ:CORT